SCHEMBL7355941

SCHEMBL7355941

CCCC(C)N[C@@H](CC(N)=O)C(N)=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ECE1 P42892 4/20 0.41
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
ALDH1A1 P00352 2/20 0.33
HPGD P15428 1/20 0.33
POLB P06746 1/20 0.33
HDAC7 Q8WUI4 1/20 0.31
HDAC8 Q9BY41 1/20 0.31
HDAC6 Q9UBN7 1/20 0.31
HDAC9 Q9UKV0 1/20 0.31
HDAC5 Q9UQL6 1/20 0.31
L3MBTL1 Q9Y468 2/20 0.31
KMT2A Q03164 2/20 0.31
HSD17B10 Q99714 1/20 0.31
LMNA P02545 1/20 0.31
ALOX15 P16050 1/20 0.31
CHRM1 P11229 1/20 0.30
AKR1A1 P14550 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7355946 1.00 ECE1 (0.41) ECE1NPC1RAB9ACA1CA2
SCHEMBL7351840 0.78 ECE1 (0.46) ECE1TDP1
SCHEMBL7351838 0.78 ECE1 (0.46) ECE1TDP1
SCHEMBL5144356 0.76 ECE1 (0.45) ECE1
SCHEMBL5430130 0.76 ECE1 (0.45) ECE1
SCHEMBL8634864 0.75 CA2 (0.43) ECE1CA1CA2ALOX15
SCHEMBL23222804 0.73 ECE1 (0.47) ECE1RAB9ACA1CA2ALDH1A1
SCHEMBL29697562 0.72 ALOX15 (0.44) ECE1CA1CA2KMT2AALOX15
SCHEMBL8523104 0.72 ECE1 (0.41) ECE1
SCHEMBL8523106 0.72 ECE1 (0.41) ECE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1005448-A2 NOVEL INHIBITORS OF AGGRECANASE AND MATRIX METALLOPROTEINASES FOR THE TREATMENT OF ARTHRITIS Du Pont Pharmaceuticals Company (US) 2000-06-07 EP disclosed
WO-1999009000-A2 NOVEL INHIBITORS OF AGGRECANASE AND MATRIX METALLOPROTEINASES FOR THE TREATMENT OF ARTHRITIS DU PONT PHARMACEUTICALS COMPANY (US) 1999-02-25 WO disclosed